After the genome, AstraZeneca taps ‘secretome’ for novel drugs

LONDON (Reuters) – AstraZeneca is diving into the world of proteins secreted by cells – collectively known as the secretome – in the hunt for new drugs and better “cell factories” for making biotech medicines.

—> Read More

facebooktwittergoogle_plusredditpinterestlinkedinmail